Physician profile
Madar Abed
NPI 1235165275
$100,119.91
in general payments reported to CMS, 2019-2025
52 companies · $16K in 2025
The $16K reported for 2025 was more than what 96% of Cardiovascular Disease providers received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,540 · 2020: $11K · 2021: $34K · 2022: $13K · 2023: $20K · 2024: $4,461 · 2025: $16K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $17K · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $12K · Food and Beverage: $11K · Education: $7.51.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $16,990.38 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $12,450.00 |
| Food and Beverage | $10,867.95 |
| Education | $7.51 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $67,024.91 | 2021-2025 | Micra, Diamondtemp Bidirectional Ablation Catheter, Aurora Ev-Icd Mri Surescan |
| Medtronic Vascular, INC. | $10,147.77 | 2019-2020 | |
| Biotronik INC. | $5,681.87 | 2019-2025 | Acticor 7 Vr-T Dx, Selectra, Biomonitor |
| Boston Scientific Corporation | $5,653.12 | 2019-2025 | Farapulse, Electrophysiology Cable, Watchman Flx |
| Abbott Laboratories | $5,256.02 | 2019-2025 | Aveir, Gallant, Tacticath Ablation Catheter, Sensor Enabled |
| Atricure, INC. | $1,305.61 | 2021-2025 | Epi-Sense Guided Coagulation System With Visitrax, Atriclip Laa Exclusion System |
| Novartis Pharmaceuticals Corporation | $920.86 | 2019-2025 | |
| Medical Device Business Services, INC. | $612.85 | 2024 | Carto 3 |
| Merck Sharp & Dohme LLC | $363.56 | 2021-2025 | Verquvo |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $346.26 | 2019-2025 | Lifevest |
| Janssen Pharmaceuticals, INC | $268.98 | 2019-2023 | Xarelto |
| Novo Nordisk INC | $246.91 | 2021-2022 | |
| Impulse Dynamics (USA) INC. | $243.55 | 2023 | Optimizer |
| Pfizer INC. | $200.95 | 2019-2024 | |
| Philips North America LLC | $193.88 | 2019 |
Show all 52 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Madar Abed listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.